Description: Imricor Medical Systems, Inc. is a United States-based medical device company. The Company is focused on designing, manufacturing and selling magnetic resonance imaging (MRI)-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include the Advantage- mitral regurgitation (MR) electrophysiology (EP) Recorder/Stimulator System, the Vision-MR Ablation Catheter and the Vision-MR Dispersive Electrode. Its Advantage-MR EP Recorder/Stimulator is an electrophysiology amplifier and recording system with integrated cardiac stimulator. Vision-MR Ablation Catheter is an irrigated tip, single-use radiofrequency (RF) ablation catheter. Vision-MR Dispersive Electrode is a dispersive electrode. The Advantage-MR EP Recorder/Stimulator System is capital equipment which can be used in multiple procedures.
Home Page: www.imricor.com
IMR Technical Analysis
400 Gateway Boulevard
Burnsville,
MN
55337
United States
Phone:
952 818 8400
Officers
| Name | Title |
|---|---|
| Mr. Steve Wedan | Pres, CEO & Exec. Chairman |
| Mr. Gregg Stenzel | Chief Operating Officer |
| Mr. Jonathon Gut | CFO, Controller, Director & VP of Fin. |
| Mr. Greg Englehardt | Exec. Director of Sales |
| Mr. Nick Twohy | VP of Marketing & Bus. Devel. |
| Mr. Kobe Lizheng | Company Sec. & Local Agent |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.9932 |
| Price-to-Sales TTM: | 69.7459 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |